Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2163733
Max Phase: Preclinical
Molecular Formula: C11H10NNaO3S
Molecular Weight: 237.28
Molecule Type: Small molecule
Associated Items:
ID: ALA2163733
Max Phase: Preclinical
Molecular Formula: C11H10NNaO3S
Molecular Weight: 237.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@]1(C(=O)[O-])CSC(c2ccccc2O)=N1.[Na+]
Standard InChI: InChI=1S/C11H11NO3S.Na/c1-11(10(14)15)6-16-9(12-11)7-4-2-3-5-8(7)13;/h2-5,13H,6H2,1H3,(H,14,15);/q;+1/p-1/t11-;/m1./s1
Standard InChI Key: ORXZPDSCPAUJQB-RFVHGSKJSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 237.28 | Molecular Weight (Monoisotopic): 237.0460 | AlogP: 1.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 69.89 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.43 | CX Basic pKa: 0.65 | CX LogP: 2.81 | CX LogD: -0.59 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.82 | Np Likeness Score: 0.58 |
1. Bergeron RJ, Wiegand J, Bharti N, McManis JS.. (2012) Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles., 55 (16): [PMID:22889170] [10.1021/jm300509y] |
Source(1):